Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Molecular Group Ships New Version of Tsar

Premium

CAMPBELL, Calif.--Oxford Molecular Group has begun shipping a new version of its Tsar software package for lead optimization and chemical library design. Tsar 3.2 will reduce time needed to create chemical compound libraries used to accelerate pharmaceutical and chemical discovery, the company said. The product offers researchers a spreadsheet interface that displays chemical structures and provides QSAR, property prediction, and statistical analysis tools. The new version includes a built-in decision-tree analytical method called Firm, automated calculation of Lipinski's rules for identifying drug-like compounds, a new library enumeration wizard, and support for prediction of new properties.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.